| Literature DB >> 33951050 |
Victoria T Hunniford1, Joshua Montroy1, Dean A Fergusson1,2, Marc T Avey3, Kimberley E Wever4, Sarah K McCann5, Madison Foster1, Grace Fox1, Mackenzie Lafreniere1, Mira Ghaly1, Sydney Mannell1, Karolina Godwinska1, Avonae Gentles1, Shehab Selim2, Jenna MacNeil2, Lindsey Sikora6, Emily S Sena7, Matthew J Page8, Malcolm Macleod7, David Moher9, Manoj M Lalu1,10.
Abstract
In an effort to better utilize published evidence obtained from animal experiments, systematic reviews of preclinical studies are increasingly more common-along with the methods and tools to appraise them (e.g., SYstematic Review Center for Laboratory animal Experimentation [SYRCLE's] risk of bias tool). We performed a cross-sectional study of a sample of recent preclinical systematic reviews (2015-2018) and examined a range of epidemiological characteristics and used a 46-item checklist to assess reporting details. We identified 442 reviews published across 43 countries in 23 different disease domains that used 26 animal species. Reporting of key details to ensure transparency and reproducibility was inconsistent across reviews and within article sections. Items were most completely reported in the title, introduction, and results sections of the reviews, while least reported in the methods and discussion sections. Less than half of reviews reported that a risk of bias assessment for internal and external validity was undertaken, and none reported methods for evaluating construct validity. Our results demonstrate that a considerable number of preclinical systematic reviews investigating diverse topics have been conducted; however, their quality of reporting is inconsistent. Our study provides the justification and evidence to inform the development of guidelines for conducting and reporting preclinical systematic reviews.Entities:
Year: 2021 PMID: 33951050 PMCID: PMC8128274 DOI: 10.1371/journal.pbio.3001177
Source DB: PubMed Journal: PLoS Biol ISSN: 1544-9173 Impact factor: 8.029